Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue

Volume: 45, Issue: 3, Pages: 402 - 411
Published: Oct 17, 2017
Abstract
Neuroblastoma may be treated with molecular radiotherapy, 131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE, directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively. This study used immunohistochemistry to evaluate target expression in archival neuroblastoma tissue, to determine whether it might facilitate clinical use of molecular radiotherapy. Tissue bank samples...
Paper Details
Title
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue
Published Date
Oct 17, 2017
Volume
45
Issue
3
Pages
402 - 411
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.